SYMBIS Brain Biopsy Robot FDA 510(k) Cleared for Procedures Inside MRI

from Medgadget.com

Deerfield Imaging (Minneapolis, MN) received FDA green light to introduce its SYMBIS stereotactic brain biopsy system in the U.S. The robotic system allows for a biopsy to be performed while the patient is inside an MRI scanner, with the goal being improved targeting and faster procedure times. Being able to visualize the target while working toward reaching it can significantly improve tissue sampling, hopefully also reducing repeat biopsies.

Since IMRIS, a part of Deerfield Imaging, produces intra-op MRIs, the SYMBIS biopsy robot nicely fits in with the company’s existing product line.

The company has plans to use the SYMBIS robot as a platform to build other tools for varying neurosurgical and maybe even other applications.

Regarding the FDA clearance, Deerfield Imaging President and CEO Jay D. Miller said, “Developing a new image-guided neurosurgical robot is a big undertaking with many challenges. This is a major milestone and the result of commitment from our team to produce core technology upon which we believe future neurosurgical applications beyond biopsy can be built.”

See the full article here.

Save time with kBLASTER's unique result management features of sorting, My Favorites, Saved Search and Search History from a web browser, so either mobile devices or computers can be used to quickly find your primary predicate, multiple predicates or reference devices to build a successful 510(k) clearance strategy. Save money in your 510(k) regulatory strategy and follow-on 510(k) submission spend by enabling self-service extraction of actionable insight from nearly 62,000 FDA medical device 510(k) clearance summaries, including more than 76,000 splash pages amounting to greater than 138,000 records.